Raymond J. Henley Iii

Array ( [id] => 6842649 [patent_doc_number] => 20030147996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-07 [patent_title] => 'Multiple antioxidant micronutrients' [patent_app_type] => new [patent_app_number] => 10/229271 [patent_app_country] => US [patent_app_date] => 2002-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2995 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20030147996.pdf [firstpage_image] =>[orig_patent_app_number] => 10229271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1245969 [patent_doc_number] => 06677342 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-01-13 [patent_title] => 'Partial fatty acid oxidation inhibitors in the treatment of congestive heart failure' [patent_app_type] => B2 [patent_app_number] => 10/228573 [patent_app_country] => US [patent_app_date] => 2002-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9948 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/677/06677342.pdf [firstpage_image] =>[orig_patent_app_number] => 10228573 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1178171 [patent_doc_number] => 06743799 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-06-01 [patent_title] => 'Use of PDE V inhibitors for improved fecundity in mammals' [patent_app_type] => B2 [patent_app_number] => 10/229534 [patent_app_country] => US [patent_app_date] => 2002-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 12 [patent_no_of_words] => 6911 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/743/06743799.pdf [firstpage_image] =>[orig_patent_app_number] => 10229534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1012771 [patent_doc_number] => 06897243 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-05-24 [patent_title] => 'Fructosamine oxidase: antagonists and inhibitors' [patent_app_type] => utility [patent_app_number] => 10/226685 [patent_app_country] => US [patent_app_date] => 2002-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9120 [patent_no_of_claims] => 109 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/897/06897243.pdf [firstpage_image] =>[orig_patent_app_number] => 10226685 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1372005 [patent_doc_number] => 06566545 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-05-20 [patent_title] => 'Menthol derivatives and process for preparing the same' [patent_app_type] => B2 [patent_app_number] => 10/226129 [patent_app_country] => US [patent_app_date] => 2002-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 2941 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/566/06566545.pdf [firstpage_image] =>[orig_patent_app_number] => 10226129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1253568 [patent_doc_number] => 06670356 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-12-30 [patent_title] => 'Analogs of galanthamine and lycoramine as modulators of nicotinic receptors' [patent_app_type] => B2 [patent_app_number] => 10/148253 [patent_app_country] => US [patent_app_date] => 2002-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2568 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/670/06670356.pdf [firstpage_image] =>[orig_patent_app_number] => 10148253 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 972254 [patent_doc_number] => 06936639 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-30 [patent_title] => 'Nitroxyl progenitors in the treatment of heart failure' [patent_app_type] => utility [patent_app_number] => 10/226412 [patent_app_country] => US [patent_app_date] => 2002-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5909 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/936/06936639.pdf [firstpage_image] =>[orig_patent_app_number] => 10226412 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6838463 [patent_doc_number] => 20030035803 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-20 [patent_title] => 'Methods for alleviating symptoms associated with neuropathic conditions comprising administration of low levels of antibodies' [patent_app_type] => new [patent_app_number] => 10/223498 [patent_app_country] => US [patent_app_date] => 2002-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7971 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20030035803.pdf [firstpage_image] =>[orig_patent_app_number] => 10223498 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7434302 [patent_doc_number] => 20040209941 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-21 [patent_title] => 'Treatment of lipodystrophy' [patent_app_type] => new [patent_app_number] => 10/485018 [patent_app_country] => US [patent_app_date] => 2004-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2367 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20040209941.pdf [firstpage_image] =>[orig_patent_app_number] => 10485018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6725533 [patent_doc_number] => 20030207845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-06 [patent_title] => 'Method and compositions for treating an inflammatory disease' [patent_app_type] => new [patent_app_number] => 10/203226 [patent_app_country] => US [patent_app_date] => 2002-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3478 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20030207845.pdf [firstpage_image] =>[orig_patent_app_number] => 10203226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1189114 [patent_doc_number] => 06734188 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-05-11 [patent_title] => 'Composition for treatment of constipation and irritable bowel syndrome' [patent_app_type] => B1 [patent_app_number] => 10/111850 [patent_app_country] => US [patent_app_date] => 2002-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3430 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/734/06734188.pdf [firstpage_image] =>[orig_patent_app_number] => 10111850 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1134871 [patent_doc_number] => 06784177 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-08-31 [patent_title] => 'Methods using hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate' [patent_app_type] => B2 [patent_app_number] => 10/210113 [patent_app_country] => US [patent_app_date] => 2002-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9369 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/784/06784177.pdf [firstpage_image] =>[orig_patent_app_number] => 10210113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1261820 [patent_doc_number] => 06664270 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-12-16 [patent_title] => 'Method and composition for treatment of irritable bowel disease' [patent_app_type] => B2 [patent_app_number] => 10/209638 [patent_app_country] => US [patent_app_date] => 2002-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11223 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 181 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/664/06664270.pdf [firstpage_image] =>[orig_patent_app_number] => 10209638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6697363 [patent_doc_number] => 20030109557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Treatment of renal disorders' [patent_app_type] => new [patent_app_number] => 10/210229 [patent_app_country] => US [patent_app_date] => 2002-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3990 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0109/20030109557.pdf [firstpage_image] =>[orig_patent_app_number] => 10210229 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7964267 [patent_doc_number] => 06680294 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-01-20 [patent_title] => 'Methods and compositions for increasing the anaerobic working capacity in tissues' [patent_app_type] => B2 [patent_app_number] => 10/209169 [patent_app_country] => US [patent_app_date] => 2002-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 21 [patent_no_of_words] => 7002 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/680/06680294.pdf [firstpage_image] =>[orig_patent_app_number] => 10209169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6736130 [patent_doc_number] => 20030013765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'Fluid therapy with l-lactate and/or pyruvate anions' [patent_app_type] => new [patent_app_number] => 10/207114 [patent_app_country] => US [patent_app_date] => 2002-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6021 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20030013765.pdf [firstpage_image] =>[orig_patent_app_number] => 10207114 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1193199 [patent_doc_number] => 06730673 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-05-04 [patent_title] => 'Pharmaceutical solutions of levosimendan' [patent_app_type] => B1 [patent_app_number] => 10/070689 [patent_app_country] => US [patent_app_date] => 2002-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3746 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/730/06730673.pdf [firstpage_image] =>[orig_patent_app_number] => 10070689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1236024 [patent_doc_number] => 06689774 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-02-10 [patent_title] => 'Zinc ionophores as therapeutic agents' [patent_app_type] => B2 [patent_app_number] => 10/205973 [patent_app_country] => US [patent_app_date] => 2002-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 24 [patent_no_of_words] => 16667 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/689/06689774.pdf [firstpage_image] =>[orig_patent_app_number] => 10205973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6835236 [patent_doc_number] => 20030162782 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-28 [patent_title] => 'Treatment of neuropathy' [patent_app_type] => new [patent_app_number] => 10/206615 [patent_app_country] => US [patent_app_date] => 2002-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9641 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20030162782.pdf [firstpage_image] =>[orig_patent_app_number] => 10206615 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6324452 [patent_doc_number] => 20020197340 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-26 [patent_title] => 'Chromium picolinate compositions and uses threof' [patent_app_type] => new [patent_app_number] => 10/207748 [patent_app_country] => US [patent_app_date] => 2002-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3504 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20020197340.pdf [firstpage_image] =>[orig_patent_app_number] => 10207748 [rel_patent_id] =>[rel_patent_doc_number] =>)